Kevin Fischbeck
Stock Analyst at B of A Securities
(3.25)
# 947
Out of 4,829 analysts
162
Total ratings
64.96%
Success rate
5.41%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $23.84 | +86.66% | 6 | Feb 28, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $380 → $370 | $353.70 | +4.61% | 9 | Jan 27, 2025 | |
| HUM Humana | Upgrades: Neutral | $247 → $308 | $249.53 | +23.43% | 14 | Nov 6, 2024 | |
| ARDT Ardent Health Partners | Downgrades: Neutral | $22 → $19 | $14.52 | +30.85% | 2 | Nov 6, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $675 → $650 | $380.64 | +70.77% | 21 | Oct 16, 2024 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $22.00 | +118.18% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $2.89 | +3.81% | 2 | Oct 2, 2024 | |
| DVA DaVita | Maintains: Underperform | $139 → $145 | $143.76 | +0.86% | 12 | Aug 7, 2024 | |
| ELV Elevance Health | Downgrades: Neutral | $646 → $530 | $404.58 | +31.00% | 3 | Jul 18, 2024 | |
| MOH Molina Healthcare | Downgrades: Underperform | $439 | $322.20 | +36.25% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $8.58 | -24.20% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $15.12 | -52.03% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $79 → $72 | $62.79 | +14.67% | 11 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $333.46 | +4.96% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 | $181.78 | +0.67% | 14 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $22.16 | +103.07% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $116.41 | -36.43% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.50 | +57.14% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $14.92 | +134.58% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $3.51 | +184.90% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 → $50 | $148.83 | -66.40% | 4 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $14.01 | -46.47% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $31.84 | -43.47% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $14.53 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $27.66 | -31.31% | 2 | Feb 9, 2018 |
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $23.84
Upside: +86.66%
HCA Healthcare
Jan 27, 2025
Maintains: Buy
Price Target: $380 → $370
Current: $353.70
Upside: +4.61%
Humana
Nov 6, 2024
Upgrades: Neutral
Price Target: $247 → $308
Current: $249.53
Upside: +23.43%
Ardent Health Partners
Nov 6, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $14.52
Upside: +30.85%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $675 → $650
Current: $380.64
Upside: +70.77%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $22.00
Upside: +118.18%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $2.89
Upside: +3.81%
DaVita
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $143.76
Upside: +0.86%
Elevance Health
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $404.58
Upside: +31.00%
Molina Healthcare
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $322.20
Upside: +36.25%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $8.58
Upside: -24.20%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $15.12
Upside: -52.03%
Sep 5, 2023
Upgrades: Neutral
Price Target: $79 → $72
Current: $62.79
Upside: +14.67%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $333.46
Upside: +4.96%
Jul 27, 2023
Maintains: Buy
Price Target: $183
Current: $181.78
Upside: +0.67%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $22.16
Upside: +103.07%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $116.41
Upside: -36.43%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.50
Upside: +57.14%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $14.92
Upside: +134.58%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $3.51
Upside: +184.90%
Jan 5, 2021
Upgrades: Buy
Price Target: $45 → $50
Current: $148.83
Upside: -66.40%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $14.01
Upside: -46.47%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $31.84
Upside: -43.47%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $14.53
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $27.66
Upside: -31.31%